[ad_1]
At the last trading session, Aphria Inc. (APHA) closed at $ 9.57, marking a -1.95% increase over the previous day. This was below the 0.3% daily gain of the S & P 500. Elsewhere, the Dow lost 0.38%, while the technology-driven Nasdaq added 0.44%.
Prior to today's trading, the company's stock had gained 16.47% over the past month. That exceeded the 2.07% gain in the medical sector and the 2.91% gain of the S & P 500 during this period.
APHA will seek to show vigor as it approaches its next release of results. According to projections, APHA would record a profit of -0.04 USD per share that day, which would represent a drop of one year on the other of 166.67%. At the same time, Zacks' estimated consensus revenue forecasts net sales of $ 41.11 million, up 403.74% over the same period last year.
Consensus estimates of Zacks, established by APHA for the entire year, expect a profit of $ 0.11 per share and a business figure of $ 129.24 million. These results would represent variations from one year to the other of -21.43% and + 344.96%, respectively.
Any recent changes in analyst estimates for APHA should also be noted by investors. These revisions generally reflect the latest short-term business trends, which can change frequently. As a result, we can interpret the revisions of positive estimates as a positive sign of the company's business outlook.
Our research shows that these estimation changes are directly related to short-term share prices. To take advantage of this, we have developed the Zacks Rank, an exclusive model that takes into account these changes in estimates and provides a usable scoring system.
Ranging from # 1 (strong buy) to # 5 (solid sale), the Zacks ranking system has proven itself outside the outperformance audit, with # 1 stocks averaging + 25% per year since 1988. The Zacks Consensus The estimate of EPS has increased by 20.54% over the last month. APHA is currently displaying Rank 3 of Zacks (pending).
In terms of valuation, APHA is currently trading at a Forward P / E ratio of 86.76. Its industry has an average average P / E of 25.01; it can be concluded that APHA is trading at a premium.
The medical products sector is part of the medical sector. This group has a Zacks industry ranking of 75, which places it in the top 30% of 250 industries and more.
The Zacks industry ranking is ranked from best to worst in terms of Zacks' average ranking of individual companies in each of these sectors. Our research shows that the 50% of the top rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all these stock transfer steps, and more, on Zacks.com.
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "
Do you want to know the latest Zacks Investment Research recommendations? Today, you can download 7 best actions for the next 30 days. Click to get this free report
& nbsp;
To read this article on Zacks.com, click here."data-reactid =" 33 ">
Do you want to know the latest Zacks Investment Research recommendations? Today, you can download 7 best actions for the next 30 days. Click to get this free report
To read this article on Zacks.com, click here.
[ad_2]
Source link